Meet Wayde McMillan: 3M's New CFO Driving Innovation in Healthcare

Wayde McMillan has been appointed as the chief financial officer of 3M's Health Care Business Group, effective November 1. With over 25 years of leadership experience in innovative companies, McMillan brings a wealth of expertise in driving profitable growth in the ever-changing healthcare industry. In this article, we will explore McMillan's background, his previous roles, and the valuable insights he will bring to 3M's Health Care Business Group.

Wayde McMillan: A New CFO Driving Innovation

Discover the background and expertise of Wayde McMillan, the newly appointed CFO of 3M's Health Care Business Group.

Wayde McMillan brings over 25 years of leadership experience in innovative companies, making him the ideal candidate for the role of CFO at 3M's Health Care Business Group. With his deep understanding of the med-tech industry and finance expertise, McMillan is poised to drive innovation and profitable growth in the healthcare sector.

As the new CFO, McMillan will play a crucial role in advancing the spin off of 3M's Health Care business and building a leading independent medical technology innovation company. His ability to build strong teams and navigate ever-changing environments will be instrumental in shaping the future of 3M's Health Care Business Group.

Previous Roles and Expertise

Explore Wayde McMillan's previous roles and his expertise in the med-tech industry.

Prior to joining 3M, Wayde McMillan served as the Executive Vice President, CFO, and Treasurer at Insulet, an innovative medical device company. During his time at Insulet, McMillan played a key role in improving the lives of people with diabetes and other conditions through the development of cutting-edge medical devices.

Before his tenure at Insulet, McMillan held various leadership positions at Medtronic and Covidien. As the CFO and Vice President of Finance of the Minimally Invasive Therapies Group at Medtronic, he managed a multi-billion dollar revenue business with a global finance team. His experience in managing large-scale operations and driving financial growth will be invaluable in his new role at 3M.

Driving Innovation in Healthcare

Learn how Wayde McMillan's finance expertise and med-tech industry understanding will contribute to building a leading independent medical technology innovation company.

Wayde McMillan's deep understanding of the med-tech industry and finance expertise will be instrumental in driving innovation in healthcare. With his leadership, 3M's Health Care Business Group is poised to become a leading independent medical technology innovation company.

McMillan's ability to navigate the ever-changing healthcare landscape and build strong teams will be crucial in developing groundbreaking medical technologies. By leveraging his finance expertise, 3M's Health Care Business Group can invest in research and development, bringing innovative solutions to patients and healthcare providers.

Conclusion

Wayde McMillan's appointment as the CFO of 3M's Health Care Business Group brings a wealth of expertise and experience to the company. With his deep understanding of the med-tech industry and finance expertise, McMillan is well-equipped to drive innovation and profitable growth in the healthcare sector.

His previous roles at Insulet, Medtronic, and Covidien have provided him with valuable insights into the industry, and his ability to build strong teams and navigate ever-changing environments will be instrumental in shaping the future of 3M's Health Care Business Group.

Under McMillan's leadership, 3M's Health Care Business Group is poised to become a leading independent medical technology innovation company, bringing groundbreaking solutions to patients and healthcare providers.

Post a Comment

Previous Post Next Post